Menu
GWAS Study

Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.

Jin Y, Andersen G, Yorgov D et al.

27723757 PubMed ID
GWAS Study Type
44266 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JY
Jin Y
AG
Andersen G
YD
Yorgov D
FT
Ferrara TM
BS
Ben S
BK
Brownson KM
HP
Holland PJ
BS
Birlea SA
SJ
Siebert J
HA
Hartmann A
LA
Lienert A
VG
van Geel N
LJ
Lambert J
LR
Luiten RM
WA
Wolkerstorfer A
WV
Wietze van der Veen JP
BD
Bennett DC
TA
Taïeb A
EK
Ezzedine K
KE
Kemp EH
GD
Gawkrodger DJ
WA
Weetman AP
KS
Kõks S
PE
Prans E
KK
Kingo K
KM
Karelson M
WM
Wallace MR
MW
McCormack WT
OA
Overbeck A
MS
Moretti S
CR
Colucci R
PM
Picardo M
SN
Silverberg NB
OM
Olsson M
VY
Valle Y
KI
Korobko I
BM
Böhm M
LH
Lim HW
HI
Hamzavi I
ZL
Zhou L
MQ
Mi QS
FP
Fain PR
SS
Santorico SA
SR
Spritz RA
Chapter II

Abstract

Summary of the research findings

Vitiligo is an autoimmune disease in which depigmented skin results from the destruction of melanocytes, with epidemiological association with other autoimmune diseases. In previous linkage and genome-wide association studies (GWAS1 and GWAS2), we identified 27 vitiligo susceptibility loci in patients of European ancestry. We carried out a third GWAS (GWAS3) in European-ancestry subjects, with augmented GWAS1 and GWAS2 controls, genome-wide imputation, and meta-analysis of all three GWAS, followed by an independent replication. The combined analyses, with 4,680 cases and 39,586 controls, identified 23 new significantly associated loci and 7 suggestive loci. Most encode immune and apoptotic regulators, with some also associated with other autoimmune diseases, as well as several melanocyte regulators. Bioinformatic analyses indicate a predominance of causal regulatory variation, some of which corresponds to expression quantitative trait loci (eQTLs) at these loci. Together, the identified genes provide a framework for the genetic architecture and pathobiology of vitiligo, highlight relationships with other autoimmune diseases and melanoma, and offer potential targets for treatment.

2,853 European ancestry cases and 37,405 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

44266
Total Participants
GWAS
Study Type
Yes
Replicated
1,827 European ancestry cases and 2,181 European ancestry controls
Replication Participants
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.